DH Definitive Healthcare Corp.
Services-Prepackaged Software · Nasdaq · SEC CIK 1861795 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-6.2%
TTM net income YoY16.7%
TTM EPS YoY12.8%
Revenue 3-yr CAGR-2.6%
Net income 3-yr CAGR—
Margins
Gross margin75.4%
Operating margin-105.4%
Net margin-69.2%
FCF margin10.6%
EBITDA margin-96.9%
Returns
ROE-73.1%
ROA-25.3%
ROIC (approx.)-80.5%
Asset turnover0.37x
Leverage & solvency
Liabilities / assets61.4%
Debt / equity1.09x
Current ratio1.96x
Interest coverage-22.22x
Cash quality & payout
Operating cash flow / net income-0.24x
Accruals ratio-31.3%
Payout ratio—
Capex / revenue5.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $54.65M | $55.20M | $55.93M | $61.53M | $60.05M | $60.75M | $59.19M | $62.29M |
| Cost of revenue | $12.42M | $14.65M | $14.28M | $14.62M | $14.05M | $14.14M | $15.43M | $14.69M |
| Gross profit | $42.23M | $40.54M | $41.65M | $46.91M | $45.99M | $46.61M | $43.76M | $47.60M |
| R&D expense | $6.67M | $6.76M | $6.50M | $9.95M | $7.55M | $7.97M | $9.30M | $8.98M |
| SG&A expense | $12.79M | $10.81M | $12.08M | $14.32M | $12.36M | $12.67M | $12.27M | $8.50M |
| Operating income | -$4.97M | -$6.75M | -$201.29M | -$26.63M | -$8.69M | -$4.17M | -$184.79M | -$99.56M |
| Interest expense | $2.66M | $2.63M | $2.63M | $2.87M | $3.00M | $2.99M | $2.43M | $3.51M |
| Pretax income | -$5.91M | -$7.80M | -$195.79M | -$17.20M | -$17.27M | -$8.81M | -$165.98M | -$90.61M |
| Income tax | -$502,000 | -$345,000 | -$3.44M | -$53,000 | $524,000 | $456,000 | -$10.89M | -$5.89M |
| Net income | -$3.89M | -$5.42M | -$138.62M | -$9.31M | -$14.84M | -$7.55M | -$107.23M | -$59.08M |
| EBITDA | $3.83M | $1.79M | -$200.29M | -$25.64M | $388,000 | $4.83M | -$184.19M | -$99.04M |
| EPS (basic) | -0.04 | -0.05 | -1.32 | — | -0.14 | -0.07 | -0.95 | — |
| EPS (diluted) | -0.04 | -0.05 | -1.32 | — | -0.14 | -0.07 | -0.95 | — |
| Weighted avg. shares (diluted) | 106.77M | 105.81M | 104.68M | — | 103.78M | 106.82M | 112.78M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $177.14M | $170.87M | $157.65M | $163.63M | $108.32M | $80.98M | $106.10M | $105.38M |
| Short-term investments | $12.85M | $12.73M | $20.45M | $17.26M | $77.61M | $103.22M | $94.57M | $184.79M |
| Receivables | $29.51M | $30.97M | $38.94M | $51.98M | $34.37M | $37.51M | $42.92M | $53.20M |
| Current assets | $243.73M | $240.10M | $245.76M | $257.61M | $246.32M | $249.19M | $273.44M | $370.17M |
| PP&E, net | $15.15M | $14.75M | $13.80M | $12.68M | $11.66M | $10.51M | $9.48M | $3.79M |
| Goodwill | $0 | $0 | $0 | $197.22M | $216.75M | $216.75M | $216.75M | $393.28M |
| Intangibles | $211.34M | $222.72M | $235.43M | $247.48M | $260.08M | $271.24M | $284.71M | $297.93M |
| Total assets | $488.65M | $496.83M | $514.74M | $735.49M | $755.53M | $770.14M | $808.66M | $1.09B |
| Current liabilities | $124.16M | $129.06M | $140.40M | $156.79M | $153.88M | $151.25M | $156.08M | $161.16M |
| Short-term debt | $8.75M | $8.75M | $8.75M | $8.75M | $8.75M | $8.75M | $8.75M | $13.75M |
| Long-term debt | $149.78M | $151.88M | $153.99M | $156.09M | $158.19M | $160.28M | $162.38M | $229.37M |
| Total debt | $158.53M | $160.63M | $162.74M | $164.84M | $166.94M | $169.03M | $171.13M | $243.12M |
| Total liabilities | $300.19M | $308.97M | $324.04M | $356.50M | $365.86M | $358.91M | $372.75M | $482.19M |
| Shareholders' equity | $145.33M | $144.65M | $146.23M | $281.11M | $284.85M | $303.62M | $322.78M | $444.38M |
| Net debt | -$18.60M | -$10.23M | $5.09M | $1.21M | $58.62M | $88.05M | $65.04M | $137.74M |
| Cash flow statement | ||||||||
| Operating cash flow | $11.42M | $11.46M | $11.56M | $2.72M | $15.69M | $9.30M | $26.07M | $8.13M |
| Capital expenditure | $2.39M | $2.94M | $3.20M | $4.44M | $2.28M | $2.29M | $7.71M | $10.90M |
| Free cash flow | $9.04M | $8.51M | $8.36M | -$1.72M | $13.41M | $7.01M | $18.36M | -$2.77M |
| Investing cash flow | -$2.39M | $4.90M | -$6.22M | $56.35M | $24.14M | -$10.16M | $83.55M | -$26.27M |
| Financing cash flow | -$2.44M | -$3.02M | -$10.88M | -$3.91M | -$12.47M | -$24.70M | -$109.71M | -$13.37M |
| Depreciation & amortization | $8.79M | $8.54M | $1.00M | $991,000 | $9.08M | $9.00M | $591,000 | $526,000 |
| Stock-based compensation | $5.53M | $5.25M | $5.22M | $8.16M | $6.68M | $6.98M | $7.32M | $7.37M |
| Share buybacks | $0 | $0 | $0 | $0 | $9.22M | $19.08M | $21.16M | $7.33M |
Free plan shows the latest 8 periods; Pro shows all 27 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.